SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-20-000019
Filing Date
2020-05-01
Accepted
2020-05-01 16:37:49
Documents
76
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2020q110-q.htm   iXBRL 10-Q 1739594
2 EXHIBIT 3.2 a2020q110-qexhibit32.htm EX-3.2 102092
3 EXHIBIT 31.1 a2020q110-qexhibit311.htm EX-31.1 14560
4 EXHIBIT 31.2 a2020q110-qexhibit312.htm EX-31.2 14421
5 EXHIBIT 32.1 a2020q110-qexhibit321.htm EX-32.1 11927
11 chart-46ee851a54315f11b13.jpg GRAPHIC 20588
12 chart-c6f6127e7bb55486951.jpg GRAPHIC 15427
  Complete submission text file 0000875320-20-000019.txt   8383592

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20200331.xsd EX-101.SCH 42630
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20200331_cal.xml EX-101.CAL 89855
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20200331_def.xml EX-101.DEF 260548
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20200331_lab.xml EX-101.LAB 620701
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20200331_pre.xml EX-101.PRE 387740
65 EXTRACTED XBRL INSTANCE DOCUMENT a2020q110-q_htm.xml XML 1762197
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 20841395
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences